Advertisement

Genetically Controlled Resistance to Viruses

  • Margo A. Brinton
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 162)

Abstract

Historically, the first demonstrations of the existence of host genes that could control resistance to disease induced by an animal virus were reported independently by Lynch and Hughes (1) and Webster and Clow (2) in 1936. Subsequently, a number of other genes have been identified in various strains of inbred mice, each of which confers resistance to a specific type of virus infection (3,4,5). Since different families of viruses vary greatly in their modes of replication, it would be expected a priori that the various resistance gene products would also differ in their mechanisms of action. Host resistance genes may act on a particular virus infection at the level of receptors, intracellular replication, interferon inhibition, or the immune response. A host resistance gene can therefore be an important component in determining the outcome of a particular virus infection. However, the severity of a virus-induced disease is the result of the interaction between host resistance genes, viral virulence genes, and the host defense system.

Keywords

West Nile Virus Resistant Cell Inbred Mouse Susceptible Cell Yellow Fever Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lynch, C.J. and Hughes, T.P. (1936). Genetics 21:104.PubMedGoogle Scholar
  2. 2.
    Webster, L.T. and Clow, A.D. (1936). J. Exp. Med. 63:827.PubMedCrossRefGoogle Scholar
  3. 3.
    Pincus, T. and Snyder, H.W. (1975). Viral Immunology andImmunopathology, ed. A. Notkins, Academic Press, New York, pp. 167.Google Scholar
  4. 4.
    Bang, F.B. (1978). In Advances in Virus Research, 23:269.Google Scholar
  5. 5.
    Brinton, M.A. and Nathanson, N. (1981). Epidemiologic Reviews, 3, 115.PubMedGoogle Scholar
  6. 6.
    Darnell, M.B., Koprowski, H. and Lagerspetz, M. (1974). J. Infect. Dis. 129:240.PubMedCrossRefGoogle Scholar
  7. 7.
    Webster, L.T. (1937). J. Exp. Med. 65:261.PubMedCrossRefGoogle Scholar
  8. 8.
    Sabin, A.B. (1952). Proc. Nat. Acad. Sci. USA, 38:540.PubMedCrossRefGoogle Scholar
  9. 9.
    Martinez, D., Brinton, M.A., Tachovsky, T.G. and Phelps, A.H. (1980). Infect. Immun. 27:979.PubMedGoogle Scholar
  10. 10.
    Lindenmann, J. (1964). Proc. Soc. Exp. Biol. (N.Y.) 116:506.Google Scholar
  11. 11.
    Neighbour, P.A., Rager-Zisman, B., and Bloom, B.R. (1978). Infect. Immun. 21:764.PubMedGoogle Scholar
  12. 12.
    Bang, F.B., and Warwick, A. (1960). Proc. Nat. Acad. Sci. USA, 46:1065.PubMedCrossRefGoogle Scholar
  13. 13.
    Virelizier, J.L., Dayan, A.D. and Allison, A.C. (1975). Infect. Immun. 12:1127.PubMedGoogle Scholar
  14. 14.
    Levy-LeBlond, E., Oth, D., and Dupuy, J.M. (1979). J. Immunol. 122:1359.PubMedGoogle Scholar
  15. 15.
    Stohlman, S.A., and Frelinger, J.A. (1980). In Genetic Controlof Natural Resistance to Infection and Malignancy, E. Shamene, P.A.L. Kougshaven and M. Landy, eds., Academic Press, New York, pp. 247.Google Scholar
  16. 16.
    Onodera, T., Yoon, J.W., Brown, K.S. and Notkins, A.L. (1978). Nature, 274:693.PubMedCrossRefGoogle Scholar
  17. 17.
    Pincus, T., Hartley, T.W. and Rowe, W.P. (1971). J. Exp. Med. 133:1234.PubMedCrossRefGoogle Scholar
  18. 18.
    Lilly, F. (1970). J. Nat. Cancer Inst. 45:163.PubMedGoogle Scholar
  19. 19.
    Rowe, W.P. (1972). J. Exp. Med. 136:1272.PubMedCrossRefGoogle Scholar
  20. 20.
    Lilly, F., Duran-Reynolds, M.L., and Rowe, W.P. (1975). J. Exp. Med. 141:882.PubMedGoogle Scholar
  21. 21.
    Lilly, F. (1966). J. Nat. Cancer Inst. 22:631.Google Scholar
  22. 22.
    Chesebro, B., Wehrly, K. and Stimpfling, J.H. (1974). J. Exp. Med. 140:1457.PubMedCrossRefGoogle Scholar
  23. 23.
    Chesebro, B., and Wehrly, K. (1978). J. Immunol. 120:1081.PubMedGoogle Scholar
  24. 24.
    Doig, D., and Chesebro, B. (1979). J. Exp. Med. 150:10.PubMedCrossRefGoogle Scholar
  25. 25.
    Lopez, C. (1975). Nature 258:152.PubMedCrossRefGoogle Scholar
  26. 26.
    Chalmers, J. (1980). In Genetic Control of Natural Resistanceto Infection and Malignancy, E. Shamene, P.A.L. Kougshaven, and M. Landy, eds., Academic Press, New York, pp. 283.Google Scholar
  27. 27.
    Chang, S.S. and Hildemann, W.H. (1964). J. Nat. Cancer Inst. 33:303.PubMedGoogle Scholar
  28. 28.
    Kees, U. and Blanden, R.V. (1976). J. Exp. Med. 143:450.PubMedCrossRefGoogle Scholar
  29. 29.
    Goodman, G.T. and Koprowski, H. (1962). J. Cell Comp. Physiol. 59:333.PubMedCrossRefGoogle Scholar
  30. 30.
    Hanson, B. and Koprowski, H. (1969). Microbios. 1B:51.Google Scholar
  31. 31.
    Jacoby, R.O. and Bhatt, P.N. (1976). J. Infect. Dis. 134:158.PubMedCrossRefGoogle Scholar
  32. 32.
    Jacoby, R.O., Bhatt, P.N., and Schwartz, A. (1980). J. Infect. Dis. 141:617.PubMedCrossRefGoogle Scholar
  33. 33.
    Darnell, M.B. and Koprowski, H. (1974). J. Infect. Dis. 129: 248.PubMedCrossRefGoogle Scholar
  34. 34.
    Webster, L.T. and Johnson, M.S. (1941). J. Exp. Med. 74:489.PubMedCrossRefGoogle Scholar
  35. 35.
    Haller, O., Arnheiter, H., Gresser, I. and Lindenmann, J. (1979). J. Exp. Med. 149:601.PubMedCrossRefGoogle Scholar
  36. 36.
    Brinton, M.A. (1981). In Natural Resistance to Viruses andTumors, O. Haller, Ed., Curr. Top. Microbiol. Immunol. 92, pp. 1.CrossRefGoogle Scholar
  37. 37.
    Brinton, MA. (1981). J. Virol. 39, 413.PubMedGoogle Scholar
  38. 38.
    Westaway, E.G. (1980). In The Togaviruses, Biology, Structure, and Replication. W. Schlesinger, ed., Academic Press, Inc., New York, pp. 531.Google Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Margo A. Brinton
    • 1
  1. 1.Wistar InstitutePhiladelphiaUSA

Personalised recommendations